SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-084159
Filing Date
2024-10-01
Accepted
2024-10-01 17:32:57
Documents
1
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1604
  Complete submission text file 0001213900-24-084159.txt   3008
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Issuer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IN8BIO, INC. 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address
Graff Jeremy R. (Reporting) CIK: 0001975028 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41160 | Film No.: 241344556